Publications

Found 12 results
Filters: Keyword is Humans and Author is Conrath, Katja  [Clear All Filters]
2017
Joncour, A., N. Desroy, C. Housseman, X. Bock, N. Bienvenu, L. Cherel, V. Labeguere, C. Peixoto, D. Annoot, L. Lepissier, et al., "Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors.", J Med Chem, vol. 60, issue 17, pp. 7371-7392, 2017 Sep 14.
2012
Govaert, J., M. Pellis, N. Deschacht, C. Vincke, K. Conrath, S. Muyldermans, and D. Saerens, "Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.", J Biol Chem, vol. 287, issue 3, pp. 1970-9, 2012 Jan 13.
2011
Stijlemans, B., G. Caljon, S. Kumar A. Natesan, D. Saerens, K. Conrath, D. Pérez-Morga, J. N. Skepper, A. Nikolaou, L. Brys, E. Pays, et al., "High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.", PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
2009
Conrath, K., A. S. Pereira, C. E. Martins, C. G. Timóteo, P. Tavares, S. Spinelli, J. Kinne, C. Flaudrops, C. Cambillau, S. Muyldermans, et al., "Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase.", Protein Sci, vol. 18, issue 3, pp. 619-28, 2009 Mar.
Vincke, C., R. Loris, D. Saerens, S. Martinez-Rodriguez, S. Muyldermans, and K. Conrath, "General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold.", J Biol Chem, vol. 284, issue 5, pp. 3273-84, 2009 Jan 30.
2008
Hmila, I., B. Abderrazek R, D. Saerens, Z. Benlasfar, K. Conrath, M. El Ayeb, S. Muyldermans, and B. Bouhaouala-Zahar, "VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'.", Mol Immunol, vol. 45, issue 14, pp. 3847-56, 2008 Aug.
2006
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.", Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "[Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].", Med Sci (Paris), vol. 22, issue 11, pp. 914-6, 2006 Nov.
2005
Saerens, D., F. Frederix, G. Reekmans, K. Conrath, K. Jans, L. Brys, L. Huang, E. Bosmans, G. Maes, G. Borghs, et al., "Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing.", Anal Chem, vol. 77, issue 23, pp. 7547-55, 2005 Dec 1.
2004
Saerens, D., J. Kinne, E. Bosmans, U. Wernery, S. Muyldermans, and K. Conrath, "Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen.", J Biol Chem, vol. 279, issue 50, pp. 51965-72, 2004 Dec 10.
2002
Cortez-Retamozo, V., M. Lauwereys, G. Hassanzade Gh, M. Gobert, K. Conrath, S. Muyldermans, P. De Baetselier, and H. Revets, "Efficient tumor targeting by single-domain antibody fragments of camels.", Int J Cancer, vol. 98, issue 3, pp. 456-62, 2002 Mar 20.
Dumoulin, M., K. Conrath, A. Van Meirhaeghe, F. Meersman, K. Heremans, L. G. J. Frenken, S. Muyldermans, L. Wyns, and A. Matagne, "Single-domain antibody fragments with high conformational stability.", Protein Sci, vol. 11, issue 3, pp. 500-15, 2002 Mar.